Cargando…
Immune thrombocytopaenic purpura following the second dose of Pfizer COVID-19 vaccine
Immune thrombocytopaenic purpura (ITP) is often a diagnosis of exclusion with presentations ranging widely from asymptomatic patients to those with life-threatening bleeding. Secondary ITP following vaccination is relatively uncommon and underdiagnosed as majority of patients remain asymptomatic. Ca...
Autores principales: | Latef, Taroob, Howard, Leslie, Loke, Chandravathi, Tsui, Edison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442476/ http://dx.doi.org/10.1136/bcr-2022-249477 |
Ejemplares similares
-
Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis
por: Artru, Florent, et al.
Publicado: (2020) -
More, less or both?
por: Attaye, Ilias, et al.
Publicado: (2018) -
Persistent wrist monarthritis: down to the bone
por: Cheah, Jonathan Toh Leong, et al.
Publicado: (2018) -
Fulminant hepatic failure in the setting of progressive ANCA-associated vasculitis associated with a rare alpha-1 antitrypsin phenotype, ’PiEE'
por: Reilkoff, Ronald, et al.
Publicado: (2018) -
Gitelman syndrome and primary hyperparathyroidism: a rare association
por: Rego, Teresa, et al.
Publicado: (2018)